6761 - 6770 of 9117 Results
Title
Year
-
OPENTitle: Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in proteinJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 61End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00322-xBest OA location URL: https://www.nature.com/articles/s41531-022-00322-x.pdfCitation Count: 9
-
OPENTitle: Virtual exam for Parkinson’s disease enables frequent and reliable remote measurements of motor functionJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 65End Page: 65Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-022-00607-8Best OA location URL: https://www.nature.com/articles/s41746-022-00607-8.pdfCitation Count: 80
-
OPENTitle: Modelling cholinergic and dopaminergic function over time in Parkinson’s disease with and without GBA1 variantsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 316End Page: 316Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-025-01160-3Best OA location URL: https://www.nature.com/articles/s41531-025-01160-3.pdfCitation Count: 0
-
OPENTitle: Analysis of hemisphere-dependent effects of unilateral intrastriatal injection of α-synuclein pre-formed fibrils on mitochondrial protein levels, dynamics, and functionJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 78End Page: 78Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-022-01374-zBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-022-01374-zCitation Count: 13
-
OPENTitle: Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer’s disease-associated genetic variantsJournal Name: Translational PsychiatryPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 163End Page: 163Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41398-022-01913-1Best OA location URL: https://doi.org/10.1038/s41398-022-01913-1Citation Count: 25
- EEG Entropy in REM Sleep as a Physiologic Biomarker in Early Clinical Stages of Alzheimer’s Disease2023OPENTitle: EEG Entropy in REM Sleep as a Physiologic Biomarker in Early Clinical Stages of Alzheimer’s DiseaseJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 91Issue #: 4Start Page: 1557End Page: 1572Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-221152Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10039707/pdf/nihms-1865876.pdfCitation Count: 31
-
OPENTitle: Distribution of phosphorylated alpha-synuclein in non-diseased brain implicates olfactory bulb mitral cells in synucleinopathy pathogenesisJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 43End Page: 43Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00491-3Best OA location URL: https://www.nature.com/articles/s41531-023-00491-3.pdfCitation Count: 37
-
OPENTitle: Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicityJournal Name: Brain PathologyPublisher: WileyVol: 33Issue #: 2Start Page: e13130End Page: e13130Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/bpa.13130Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bpa.13130Citation Count: 4
- B lymphocyte responses in Parkinson’s disease and their possible significance in disease progression2023OPENTitle: B lymphocyte responses in Parkinson’s disease and their possible significance in disease progressionJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 5Issue #: 2Start Page: fcad060End Page: fcad060Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcad060Best OA location URL: https://academic.oup.com/braincomms/article-pdf/5/2/fcad060/49650847/fcad060.pdfCitation Count: 42
-
OPENTitle: Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson’s Disease ModelsJournal Name: AntioxidantsPublisher: MDPI AGVol: 12Issue #: 3Start Page: 582End Page: 582Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/antiox12030582Best OA location URL: https://www.mdpi.com/2076-3921/12/3/582/pdf?version=1677573522Citation Count: 14